These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11240436)

  • 41. The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems.
    Knoch M; Keller M
    Expert Opin Drug Deliv; 2005 Mar; 2(2):377-90. PubMed ID: 16296761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modified polyethylenimines as non-viral gene delivery systems for aerosol gene therapy: investigations of the complex structure and stability during air-jet and ultrasonic nebulization.
    Kleemann E; Dailey LA; Abdelhady HG; Gessler T; Schmehl T; Roberts CJ; Davies MC; Seeger W; Kissel T
    J Control Release; 2004 Dec; 100(3):437-50. PubMed ID: 15567508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liquid nebulization: emerging technologies conference summary.
    Hess DR
    Respir Care; 2002 Dec; 47(12):1471-6. PubMed ID: 12467504
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Controlled inhalation of aerosolised therapeutics.
    Bennett WD
    Expert Opin Drug Deliv; 2005 Jul; 2(4):763-7. PubMed ID: 16296800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Farnesol for aerosol inhalation: nebulization and activity against human lung cancer cells.
    Wang Z; Chen HT; Roa W; Finlay W
    J Pharm Pharm Sci; 2003; 6(1):95-100. PubMed ID: 12753732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical study of Madecassol in otorhinolaryngology].
    Riu R; Alavoine J; Auriault A; Le Mouel C
    J Med Lyon; 1966 Apr; 47(97):693-706. PubMed ID: 5940268
    [No Abstract]   [Full Text] [Related]  

  • 47. [Consensus conference on the rationale for use of anti-inflammatory agents in otorhinolaryngology].
    Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):5-40. PubMed ID: 15462021
    [No Abstract]   [Full Text] [Related]  

  • 48. Sofradex ear drops and ointment.
    Cameron J
    Med J Aust; 1980 Jan; 1(2):84. PubMed ID: 6153748
    [No Abstract]   [Full Text] [Related]  

  • 49. A validated, stability-indicating HPLC method for the determination of dexamethasone related substances on dexamethasone-coated drug-eluting stents.
    Chen Q; Zielinski D; Chen J; Koski A; Werst D; Nowak S
    J Pharm Biomed Anal; 2008 Nov; 48(3):732-8. PubMed ID: 18722070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of realistic airflow rate on aerosol generation by nebulizers.
    Vecellio L; Kippax P; Rouquette S; Diot P
    Int J Pharm; 2009 Apr; 371(1-2):99-105. PubMed ID: 19150494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aerosol therapy: the special needs of young children.
    Janssens HM; Tiddens HA
    Paediatr Respir Rev; 2006; 7 Suppl 1():S83-5. PubMed ID: 16798606
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laboratory methods for assessing vaccine potency retained in aerosol outputs from nebulizers: application to World Health Organization measles aerosol project.
    Cohen BJ; Parry RP; Andrews N; Bennett AM; Dennis JH
    Vaccine; 2008 Jun; 26(27-28):3534-9. PubMed ID: 18490082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In-line assessment of pulmonary drug delivery using light obscuration.
    Kusmartseva O; Kattige AS; Price R; Smith PR
    Biosens Bioelectron; 2004 Oct; 20(3):468-74. PubMed ID: 15494227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Smart nebulizers.
    Smaldone GC
    Respir Care; 2002 Dec; 47(12):1434-41; discussion 1441-4. PubMed ID: 12467501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of fluid physicochemical properties on vibrating-mesh nebulization.
    Ghazanfari T; Elhissi AM; Ding Z; Taylor KM
    Int J Pharm; 2007 Jul; 339(1-2):103-11. PubMed ID: 17451896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formulation of rifampicin-cyclodextrin complexes for lung nebulization.
    Tewes F; Brillault J; Couet W; Olivier JC
    J Control Release; 2008 Jul; 129(2):93-9. PubMed ID: 18514353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The comparative effectiveness of framycetin included in combined therapy of adenoiditis in the children].
    Soldatskiĭ IuL; Denisova OA; Ivanenko AM
    Vestn Otorinolaringol; 2014; (5):69-71. PubMed ID: 25588492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Therapy with aerosols in infants and small children at the otorhinolaryngology departments].
    Bláhová O; Picková M
    Z Laryngol Rhinol Otol; 1968 Aug; 47(8):620-6. PubMed ID: 5726721
    [No Abstract]   [Full Text] [Related]  

  • 59. [Instillation treatment of suppurative maxillary sinusitides].
    Münker G
    HNO; 1972 Nov; 20(11):346-8. PubMed ID: 4650167
    [No Abstract]   [Full Text] [Related]  

  • 60. [Intravenous osmotic therapy using the combination of glycerol and sodium ascorbate in otorhinolaryngology].
    Celestino D; Delfini R; Martucci E; Orofino A
    Boll Chim Farm; 1981 Feb; 120(2):75-84. PubMed ID: 7236375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.